December 2, 2020 — A 2-month-old infant diagnosed with COVID-19 (SARS-CoV-2) experienced reversible myocardial injury ...
December 2, 2020 — The Centers for Medicare and Medicaid Services (CMS) finalized updates to Medicare coverage policies ...
December 3, 2020 — GE Healthcare is introducing a new version of its robotic driven angiography system for image guided ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
December 1, 2020 – Medical imaging artificial intelligence (AI) vendor Avicenna.AI today announced its FDA-cleared CINA ...
December 1, 2020 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) ...
December 1, 2020 — A recent publication demonstrated procedural efficiency for MitraClip transcatheter mitral valve ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
November 30, 2020 — The Clarius PA HD hand-held, wireless ultrasound scanner is now available for high resolution ...
November 24, 2020 — The U.S. Food and Drug Administration (FDA) has cleared AliveCor's next generation of interpretive ...
November 24, 2020 — One-year results off the PIONEER III study comparing the safety and efficacy of the Supreme HT ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
This Frost & Sullivan Executive White Paper explains that digitization is the shift to value-based care and risk-sharing ...
Here is a list of the American Heart Association (AHA) late-breaking clinical trial presentations at the 2020 Virtual ...
Aaron Baggish, M.D., director of the cardiovascular performance program, Massachusetts General Hospital. He was on a ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 18, 2020 — A late-breaking study at the 2020 American Heart Association (AHA) Scientific Sessions showed nearly ...
November 18, 2020 — The primary results from the RIVER Trial, Rivaroxaban for Valvular Heart disease and Atrial ...
November 18, 2020 -- A new American Heart Association (AHA) collaborative model for COVID-19 (SARS-CoV-2) research ...